Global FFR as Prognosis in CAD Patients without Ischemia

Global fractional flow reserve (FFR) results from adding up FFR values of the three major coronary arteries. This figure represents the physiological atherosclerosis burden and can predict events at long term in patients without stenosis leading to ischemia.

Efecto a largo plazo de los balones liberadores con bajas dosis de paclitaxel

This recent study published in JAHA looked at major cardiovascular events (death, infarction and revascularization) at 5 years in 1122 patients with no significant stenosis (lesions with FFR > 0.8 n=275) or presenting at least one significant lesion successfully treated (post PCI FFR > 0.8 n=847).

FFR was measured in the three main coronary arteries and these values were added to stratify patients into global FFR tertiles (low ≤ 2.80, intermediate between 2.80 and 2.88, and high ≥ 2.88).

Patients in the lowest tertile presented more events at 5 years compared against the intermediate and high tertiles (27.5% vs 22.0% and 20.9%, respectively; p=0.040).

The highest events rate in the group with low global FFR was driven mainly by more revascularization (16.4% vs 11.3% and 11.8%, respectively; p=0.038).


Read also: Sapien 3 Performs Well in “Jobs” for Which It Is Not Designed.


For each additional 0.1 FFR there was a significant reduction in total events (HR 0.988; CI 95%, 0.977 to 0.998; p=0.023), infarctions (HR 0.982; CI 95%, 0.966 to 0.998; p=0.032) and revascularization (HR 0.985; CI 95%, 0.972 to 0.999; p=0.040).

This is one of the studies that most clearly shows the concept of FFR as a continuous variable with a large spectrum of greys, as opposed to a binary variable below or over 0.8. 

Conclusion

Global FFR (the added FFR values of the three main cardiac arteries) is capable of predicting events at 5 years even in patients without ischemia driven by stenosis. Global FFR can be interpreted as the burden of physiological atherosclerosis.

JAHA-120-017729free

Original Title: Global Fractional Flow Reserve Value Predicts 5-Year Outcomes in Patients With Coronary Atherosclerosis But Without Ischemia.

Reference: Stephane Fournier et al. J Am Heart Assoc. 2020;9:e017729.  DOI: 10.1161/JAHA.120.017729.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...